Similar to KRAS, BRAF is a well-known proto-oncogene and the p.V600E mutation is implicated in a number of cancers including melanoma, colorectal carcinoma, and papillary thyroid carcinoma [16–19]. Here, BRAF is linked to differentiated thyroid carcinoma.